Low-dose IL-34 has no effect on osteoclastogenesis but promotes osteogenesis of hBMSCs partly via activation of the PI3K/AKT and ERK signaling pathwaysJianxiang Xu, Zhijun Pan|Stem Cell Research & Therapy|2021Cited by 25